(−)- Epigallocatechin-3-gallate induces GRP78 accumulation in the ER and shifts mesothelioma constitutive UPR into proapoptotic ER stress

New Concepts in the Treatment of Malignant Pleural Mesothelioma

(2018) Ori Wald et al.   Annual Review of Medicine

ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells

(2017) Xun Yuan et al.   Oncotarget

Insights on the involvement of (–)-epigallocatechin gallate in ER stress-mediated apoptosis in age-related macular degeneration

(2016) Bose Karthikeyan et al.   APOPTOSIS

Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents

(2016) Ramon Colomer et al.   CURRENT DRUG TARGETS

ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases

(2016) C. Leah B. Kline et al.   Science Signaling

ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases

(2016) C. Leah B. Kline et al.   Science Signaling

Paclitaxel/Epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells

(2015) Satiesh Kumar Ramadass et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

When ER stress reaches a dead end

(2013) Hery Urra et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma

(2013) L E Dalton et al.   BRITISH JOURNAL OF CANCER

Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma

(2013) Viviana Volta et al.   PLoS One

Combination of ascorbate/epigallocatechin-3-gallate/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells

(2013) Simona Martinotti et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Structural Basis of the Unfolded Protein Response

(2012) Alexei Korennykh et al.   Annual Review of Cell and Developmental Biology

Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 – present)

(2012) Kristin Landis-Piwowar et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis

(2012) Peter C. Gray et al.   FEBS LETTERS

Epigallocatechin-3-gallate induces mesothelioma cell deathviaH2O2−dependent T-type Ca2+channel opening

(2012) Elia Ranzato et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies

(2012) B Luo et al.   ONCOGENE

Epithelial mesenchymal transition traits in honey-driven keratinocyte wound healing: Comparison among different honeys

(2012) Elia Ranzato et al.   WOUND REPAIR AND REGENERATION

Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting

(2011) Min Ni et al.   BIOCHEMICAL JOURNAL

Selective Ascorbate Toxicity in Malignant Mesothelioma

(2010) Elia Ranzato et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders

(2009) Miao Wang et al.   ANTIOXIDANTS & REDOX SIGNALING

Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways

(2009) J A Kelber et al.   ONCOGENE

Imatinib Mesylate Enhances Therapeutic Effects of Gemcitabine in Human Malignant Mesothelioma Xenografts

(2008) P. Bertino et al.   CLINICAL CANCER RESEARCH

Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells

(2008) J.É. Magyar et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY